vs
NEKTAR THERAPEUTICS（NKTR）与REDWOOD TRUST INC（RWT）财务数据对比。点击上方公司名可切换其他公司
REDWOOD TRUST INC的季度营收约是NEKTAR THERAPEUTICS的1.2倍（$25.9M vs $21.8M），REDWOOD TRUST INC净利率更高（77.2% vs -165.4%，领先242.7%），REDWOOD TRUST INC同比增速更快（-6.1% vs -25.3%），过去两年NEKTAR THERAPEUTICS的营收复合增速更高（0.4% vs -41.0%）
内克塔医疗是一家美国生物制药企业，1990年成立，总部位于加利福尼亚州旧金山。该企业依托专有的聚乙二醇化技术与先进高分子偶联技术，通过改性物质化学结构研发候选新药，可改善药物滞留性、溶解度等特性，同时也是安进、默克、辉瑞等多家知名药企的技术供应商。
Redwood Trust Inc是总部位于美国的专业房地产投资信托公司，主营住宅与商业抵押贷款、抵押贷款支持证券及房地产信贷类资产的投资管理，核心业务覆盖住宅抵押贷款发放、商业地产信贷和投资服务，客户以机构投资者和房地产市场参与者为主。
NKTR vs RWT — 直观对比
营收规模更大
RWT
是对方的1.2倍
$21.8M
营收增速更快
RWT
高出19.2%
-25.3%
净利率更高
RWT
高出242.7%
-165.4%
两年增速更快
NKTR
近两年复合增速
-41.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $21.8M | $25.9M |
| 净利润 | $-36.1M | $20.0M |
| 毛利率 | — | — |
| 营业利润率 | -126.9% | — |
| 净利率 | -165.4% | 77.2% |
| 营收同比 | -25.3% | -6.1% |
| 净利润同比 | -596.9% | 402.6% |
| 每股收益（稀释后） | $-4.67 | $0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NKTRRWT
| Q4 25 | $21.8M | $25.9M | ||
| Q3 25 | $11.8M | $15.0M | ||
| Q2 25 | $11.2M | $13.8M | ||
| Q1 25 | $10.5M | $27.9M | ||
| Q4 24 | $29.2M | $27.6M | ||
| Q3 24 | $24.1M | $25.5M | ||
| Q2 24 | $23.5M | $67.4M | ||
| Q1 24 | $21.6M | $74.5M |
净利润NKTRRWT
| Q4 25 | $-36.1M | $20.0M | ||
| Q3 25 | $-35.5M | $-7.7M | ||
| Q2 25 | $-41.6M | $-98.5M | ||
| Q1 25 | $-50.9M | $16.1M | ||
| Q4 24 | $7.3M | $-6.6M | ||
| Q3 24 | $-37.1M | $14.8M | ||
| Q2 24 | $-52.4M | $15.5M | ||
| Q1 24 | $-36.8M | $30.3M |
毛利率NKTRRWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 72.7% | — | ||
| Q3 24 | 81.6% | — | ||
| Q2 24 | 58.5% | — | ||
| Q1 24 | 60.6% | — |
营业利润率NKTRRWT
| Q4 25 | -126.9% | — | ||
| Q3 25 | -268.6% | -9.0% | ||
| Q2 25 | -324.2% | -679.0% | ||
| Q1 25 | -425.8% | 80.2% | ||
| Q4 24 | 49.2% | -1.3% | ||
| Q3 24 | -142.4% | 86.1% | ||
| Q2 24 | -211.9% | 30.3% | ||
| Q1 24 | -163.7% | 41.3% |
净利率NKTRRWT
| Q4 25 | -165.4% | 77.2% | ||
| Q3 25 | -301.3% | -51.4% | ||
| Q2 25 | -372.2% | -712.0% | ||
| Q1 25 | -486.4% | 57.8% | ||
| Q4 24 | 24.9% | -24.0% | ||
| Q3 24 | -153.6% | 58.1% | ||
| Q2 24 | -222.9% | 23.0% | ||
| Q1 24 | -170.1% | 40.6% |
每股收益（稀释后）NKTRRWT
| Q4 25 | $-4.67 | $0.11 | ||
| Q3 25 | $-1.87 | $-0.08 | ||
| Q2 25 | $-2.95 | $-0.76 | ||
| Q1 25 | $-0.24 | $0.10 | ||
| Q4 24 | $-2.07 | $-0.08 | ||
| Q3 24 | $-2.66 | $0.09 | ||
| Q2 24 | $-3.76 | $0.10 | ||
| Q1 24 | $-0.19 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $15.1M | $255.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $89.8M | $982.6M |
| 总资产 | $280.4M | $23.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NKTRRWT
| Q4 25 | $15.1M | $255.7M | ||
| Q3 25 | $41.0M | $226.3M | ||
| Q2 25 | $43.0M | $302.0M | ||
| Q1 25 | $38.9M | $259.9M | ||
| Q4 24 | $44.3M | $245.2M | ||
| Q3 24 | $30.1M | $253.7M | ||
| Q2 24 | $27.9M | $275.6M | ||
| Q1 24 | $48.6M | $275.4M |
总债务NKTRRWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $1.7B |
股东权益NKTRRWT
| Q4 25 | $89.8M | $982.6M | ||
| Q3 25 | $85.1M | $999.0M | ||
| Q2 25 | $-24.2M | $1.1B | ||
| Q1 25 | $13.7M | $1.2B | ||
| Q4 24 | $60.7M | $1.2B | ||
| Q3 24 | $48.9M | $1.2B | ||
| Q2 24 | $79.7M | $1.2B | ||
| Q1 24 | $126.7M | $1.2B |
总资产NKTRRWT
| Q4 25 | $280.4M | $23.7B | ||
| Q3 25 | $301.3M | $22.6B | ||
| Q2 25 | $207.5M | $21.3B | ||
| Q1 25 | $256.2M | $19.9B | ||
| Q4 24 | $303.9M | $18.3B | ||
| Q3 24 | $308.0M | $18.4B | ||
| Q2 24 | $343.3M | $16.5B | ||
| Q1 24 | $396.0M | $15.1B |
负债/权益比NKTRRWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-65.0M | $-10.1B |
| 自由现金流经营现金流 - 资本支出 | $-65.0M | — |
| 自由现金流率自由现金流/营收 | -298.0% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | -504.15× |
| 过去12个月自由现金流最近4个季度 | $-208.7M | — |
8季度趋势，按日历期对齐
经营现金流NKTRRWT
| Q4 25 | $-65.0M | $-10.1B | ||
| Q3 25 | $-48.8M | $-2.7B | ||
| Q2 25 | $-45.7M | $-2.1B | ||
| Q1 25 | $-49.1M | $-2.0B | ||
| Q4 24 | $-46.2M | $-5.9B | ||
| Q3 24 | $-43.9M | $-2.1B | ||
| Q2 24 | $-37.7M | $-2.0B | ||
| Q1 24 | $-47.9M | $-954.2M |
自由现金流NKTRRWT
| Q4 25 | $-65.0M | — | ||
| Q3 25 | $-48.9M | — | ||
| Q2 25 | $-45.8M | — | ||
| Q1 25 | $-49.1M | — | ||
| Q4 24 | $-46.6M | — | ||
| Q3 24 | $-44.6M | — | ||
| Q2 24 | $-37.9M | — | ||
| Q1 24 | $-48.0M | — |
自由现金流率NKTRRWT
| Q4 25 | -298.0% | — | ||
| Q3 25 | -414.5% | — | ||
| Q2 25 | -409.6% | — | ||
| Q1 25 | -469.0% | — | ||
| Q4 24 | -159.9% | — | ||
| Q3 24 | -184.9% | — | ||
| Q2 24 | -161.3% | — | ||
| Q1 24 | -222.0% | — |
资本支出强度NKTRRWT
| Q4 25 | 0.1% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 2.8% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | 0.7% | — |
现金转化率NKTRRWT
| Q4 25 | — | -504.15× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -120.92× | ||
| Q4 24 | -6.36× | — | ||
| Q3 24 | — | -140.86× | ||
| Q2 24 | — | -126.56× | ||
| Q1 24 | — | -31.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
